Effects of a hydroxyethylstarch solution on plasma colloid osmotic pressure in acutely ill patients

Acta Anaesthesiologica Belgica

Volumn 51, Issue 1, 2000, Pages 39-42

  Mbaba Mena, J ^b   De Backer, D ^b   Vincent, J L ^a  

^a ERASME HOSPITAL   (Belgium)

^b NONE

Author keywords

Human albumin solution; Hypovolemia; Oncometer; Synthetic colloid solutions

Indexed keywords

ALBUMINOID; HETASTARCH; PLASMA SUBSTITUTE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; COLLOID; CRITICAL ILLNESS; FEMALE; FLUID THERAPY; FOLLOW UP; HUMAN; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OSMOTIC PRESSURE; PHYSIOLOGY; PLASMA;

ADULT; ALBUMINS; ANALYSIS OF VARIANCE; COLLOIDS; CRITICAL ILLNESS; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; HETASTARCH; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OSMOTIC PRESSURE; PLASMA; PLASMA SUBSTITUTES;

EID: 0033658447     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Schierhout G., Roberts I., Fluid resuscitation with colloid or crystalloid solutions in critically ill patients : a systematic review of randomised trials. BR. MED. J., 316, 961-964, 1998.
2. Vincent J. L., Fluids for resuscitation, BR. J. ANAESTH., 67, 185-193, 1991.
3. Cochrane injuries group albumin reviewers, Human albumin administration in critically ill patients : systematic review of randomised controlled trials, BR. MED. J., 317, 235-240, 1998.
4. Offringa M., Excess mortality after human albumin administration in critically ill patients. BR. MED. J., 317, 223-224, 1998.
5. Camu F., Ivens D., Christiaens F., Human albumin and colloid fluid replacement : their use in surgery, ACTA ANAESTH. BELG., 46, 3-18, 1995.
6. Boldt J., Heesen M., Muller M., Pabsdorf M., Hempelmann G., The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients, ANESTH. ANALG., 83, 254-261, 1996.
7. Rackow E. C., Mecher C., Astiz M. E., Griffel M., Falk J. L., Weil M. H., Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion, CRIT. CARE MED., 17, 394-400, 1989.
8. Vogt N. H., Bothner U., Lerch G., Lindner K. H., Georgieff M., Large-dose administration of 6% hydroxyethyl starch 200/0.5 solution in total hip arthroplasty : plasma homeostasis, hemostasis, and renalfunction compared to use of 5% human albumin, ANESTH. ANALG., 83, 262-268, 1996.
9. Guidet B., Podevin P., Robert A., Chauvin P., Maurey E., Offenstadt G., High doses of hydroxyethyl starch and human albumin have similar effects on monocyte function and oncotic pressure, EUR. J. CLIN. INVEST., 27, 943-947, 1997.
10. Vermeulen L. C., Ratko T. A., Erstad B. L., Brecher M. E., Matuszewski K. A., A paradigm for consensus: The university hospital consortium guidelines for the use of albumin, nonprotein colloid and crystalloid solutions, ARCH. INTERN. MED., 155, 373-379, 1995.
11. Vincent J. L., Plasma colloid osmotic pressure, INTENSIVE CARE WORLD, 1998, 15, 84-87.
12. Hankeln K. B., Radel C., Beez M., Laniewski P., Bohmert F., Comparison of hydroxyethyl starch and lactated Ringer's solution on hemodynamics and oxygen transport of critically ill patients in prospective crossover studies, CRIT. CARE MED, 17, 133-135, 1989.
13. Waxman K., Holness R., Tominaga G., Chela P., Grimes J., Hemodynamic and oxygen transport effects of Pentastarch in burn resuscitation, ANN. SURG., 210, 341-349, 1989.
14. Nagy K. K., Davis J., Duda J., Fildes J., Roberts R., Barrett J., A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock, SHOCK, 40, 289-294, 1993.
15. Bothner U., Georgieff M., Vogt N. H., Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/ 0.5) solution : a randomized, controlled epidemiology study, ANESTH. ANALG., 86, 850-855, 1998.
16. Ring J., Messmer K., Incidence and severity of anaphylactoid reactions to colloid volume substitutes, LANCET, 1, 466-469, 1977.
17. Kupiotis S., Quehenberger P., Eichler H., et al., Effect of hydroxethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin, CRIT. CARE MED., 22, 606-612, 1994.
18. Stump D. C., Strauss R. G., Henriksen R. A., Petersen R. E., Saunders R., Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII, TRANSFUSION, 25, 349-354, 1985.
19. Scherer R., Giebler R., Kampe S., Kox W. J., Effects of hypertonic saline hydroxyethyl starch solution on collagen-inducedplatelet aggregation and ATP secretion, INFUSIONSTHER. TRANSFUSIONSMED., 21, 310-314, 1994.
20. Claes Y., Van Hemelrijck J., Van Gerven M., Arnout J., Vermylen J., Weidler B., Van Aken H., Influence of hydroxyethyl starch on coagulation in patients during the perioperative period, ANESTH. ANALG., 75, 24-30, 1992.
21. Gold M. S., Russo J., Tissot M., Weinhouse G., Riles T., Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm surgery. A prospective, randomized study, ANN. SURG., 211, 482-485, 1990.
22. Falk J. E., Rackow E. C., Astiz M. E., Weil M. H., Effects of hetastarch and albumin on coagulation in patients with septic shock, J. CLIN. PHARMACOL., 28, 412-415, 1988.
23. Trumble E. R., Muizelaar J. P., Myseros J. S., Choi S. C., Warren B. B., Coagulopathy with the use of hetastarch in the treatment of vasospasm, J. NEUROSURG., 82, 44-47, 1995.
24. Baldassarre S., Vincent J. E., Coagulopathy induced by hydroxvethyl starch, ANESTH. ANALG., 84, 451-453, 1997.
25. Cope J. T., Banks D., Mauney M. C., Lucktong T., Shockey K. S., Kron I. L., Tribble C. G., Intraoperative hetastarch infusion impairs hemostasis after cardiac operations, ANN. THORAC. SURG., 63, 78-82, 1997.
26. Warren B. B., Durieux M. E., Hydroxyethyl starch : Safe or not ?, ANESTH. ANALG., 84, 206-212, 1997.